Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9 Read more
European Commission Approves Pfizer’s PREVENAR 20 to Help Protect Infants and Children Against Pneumococcal Disease Read more
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children Read more
Johnson & Johnson submits supplemental Biologics License Application to U.S. FDA seeking approval of TREMFYA (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis Read more
SK bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline Read more
FDA Approves Opdivo (nivolumab), in Combination with Cisplatin and Gemcitabine, for First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma Read more